Treatment of Capsular Contracture with Poly-4-Hydroxybutyrate

Area of Science:

• Plastic Surgery
• Biomaterials Science

Background:

• Capsular contracture is the most common complication after breast augmentation, often necessitating revision surgery.
• Evolution of surgical techniques and materials has aimed to mitigate this frequent issue.

Purpose of the Study:

• To review the advancements in preventing and managing capsular contracture following breast augmentation.
• To highlight the role of innovative materials and surgical placements in reducing contracture rates.

Main Methods:

• Literature review of surgical techniques, antimicrobial protocols, and biomaterials used in breast augmentation.
• Analysis of the efficacy of acellular dermal matrices and biosynthetic scaffolds, including poly-4-hydroxybutyrate (P4HB).

Main Results:

• Prepectoral placement, submuscular, and dual-plane techniques have influenced contracture management.
• Acellular dermal matrices and P4HB scaffolds demonstrate effectiveness in lowering capsular contracture rates.
• P4HB offers advantages like cost-effectiveness and enhanced pocket stability.

Conclusions:

• Modern breast augmentation emphasizes prepectoral positioning combined with advanced scaffolds and antimicrobial protocols for successful contracture prevention.
• The integration of innovative biomaterials and refined surgical approaches provides consistent outcomes in managing capsular contracture.